Table 1.
Patient Characteristics
| DM (n=95) | No DM (n=227) | P Value | |
|---|---|---|---|
| Age, y | 62.3±11.6 | 57.3±11.7 | 0.001a |
| Sex | 0.029a | ||
| Male | 65 (68.4) | 181 (79.7) | |
| Female | 30 (31.6) | 46 (20.3) | |
| BMI, kg/m2 | 26.1±4.6 | 26.0±7.3 | 0.874 |
| Clinical presentation | 0.231 | ||
| STEMI | 23 (24.2) | 70 (30.8) | |
| NSTE‐ACS | 72 (75.8) | 157 (69.2) | |
| Prior MI | 13 (13.7) | 29 (12.8) | 0.825 |
| Hypertension | 68 (71.6) | 125 (55.1) | 0.006a |
| Dyslipidemia | 72 (75.8) | 157 (69.2) | 0.231 |
| Current smoking | 22 (23.2) | 86 (37.9) | 0.011a |
| Creatinine, mg/dL | 1.02±0.63 | 0.92±0.20 | 0.151 |
| LDL cholesterol, mg/dL | 103.4±44.5 | 107.1±35.7 | 0.512 |
| HbA1c, % | 7.7±1.6 | 5.6±0.5 | <0.001a |
| hs‐CRP, mg/L | 2.0 (0.7‐4.0) | 1.0 (0.3‐4.0) | 0.402 |
| Medication | |||
| Aspirin | 41 (43.2) | 73 (32.2) | 0.060 |
| Clopidogrel | 24 (25.3) | 37 (16.3) | 0.061 |
| β‐Blockers | 21 (22.1) | 37 (16.3) | 0.216 |
| ACE‐I/ARBs | 30 (31.6) | 39 (17.2) | 0.004a |
| Statins | 36 (37.9) | 62 (27.3) | 0.060 |
| DM control | |||
| Insulin | 48 (50.5) | ||
| Oral hypoglycemic agents | 27 (28.4) | ||
| Diet only | 20 (21.1) | ||
Chi‐square test for categorical variables, and Student t test and Mann‐Whitney test for continuous variables were applied. Data are presented as number (%), mean±SD, or median (interquartile range). ACE‐I indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; DM, diabetes mellitus; HbA1c, hemoglobin A1c; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; MI, myocardial infarction; NSTE‐ACS, non‐ST‐segment–elevation acute coronary syndrome; STEMI, ST‐segment–elevation myocardial infarction.
a
P<0.05.